Covid-19

Has COVID-19 pandemic proven more hostile to developing economies?

 Has COVID-19 pandemic proven more hostile to developing economies?

Highlights  Unlike advanced economies, developing countries would not be able to achieve pre-pandemic economic levels by 2023. As per the WHO, 85% of people in Africa have not received a single COVID-19 vaccine dose, while 36 countries hav...

Read More...

Bharat Biotech to commence Phase 2/3 trial of its COVID-19 vaccine on children

Bharat Biotech to commence Phase 2/3 trial of its COVID-19 vaccine on children

India-based Bharat Biotech will evaluate its COVID-19 vaccine in a Phase 2/3 clinical trial on children in the 2-18 age group. According to PTI report, the study will be performed on approximately 525 participants at several sites in India. Recent...

Read More...
All you need to know about intranasal COVID-19 treatments and vaccines

All you need to know about intranasal COVID-19 treatments and vaccines

Summary With the development of COVID-19 vaccines and medicines, scientists are now aiming to improve therapeutics and exploring different delivery routes. Amcyte Pharma’s algae-derived NasitrolTM nasal spray has demonstrated efficacy in ...

Read More...
Experts warn of more COVID-19 variants as India reels under the deadly second wave

Experts warn of more COVID-19 variants as India reels under the deadly second wave

Summary Viruses continually mutate, and sometimes new variants emerge that can persist for a longer time. Experts warn that more COVID-19 variants are anticipated to arise in the upcoming months. Meanwhile, Moderna’s new booster shot has...

Read More...
Pressure to waive off vaccine IP rights increases as COVID-19 cases continue to rise

Pressure to waive off vaccine IP rights increases as COVID-19 cases continue to rise

Summary With the surmounting COVID-19 cases, the developing countries are demanding patent exemptions on items, including vaccines, diagnostic kits, and ventilators, to fight the COVID-19 pandemic. The patent waiver will help emerging nations m...

Read More...
Are the Vaccines Working? When will Covid-19 end?

Are the Vaccines Working? When will Covid-19 end?

The deadly coronavirus pandemic was first reported from Wuhan, China in December 2019 and spread across the globe leaving economies of the biggest countries come to a standstill. No one had predicted what the outbreak could cost, and sadly it did c...

Read More...
COVID-19 Weekly Roundup: Latest developments around the world

COVID-19 Weekly Roundup: Latest developments around the world

Source: Moonhonor, Shutterstock Summary The EU Commission has opted not to renew contracts for the COVID-19 vaccine from Oxford-AstraZeneca and Johnson & Johnson. Researchers at the University of Oxford introduced a Com-Cov study to evalua...

Read More...
CDC, FDA Recommend Halting Johnson & Johnson’s One-Shot COVID Vaccine

CDC, FDA Recommend Halting Johnson & Johnson’s One-Shot COVID Vaccine

Source: solarseven, Shutterstock  Shares of Johnson & Johnson (NYSE: JNJ) fell 1.34 percent on Tuesday after the U.S. Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) recommended pausing the compan...

Read More...
Airlines Might Check New EU COVID-19 Pass Before Onboarding Travelers

Airlines Might Check New EU COVID-19 Pass Before Onboarding Travelers

Source: diy13, Shutterstock Summary European Union (EU) plans to roll out a digital travel certificate to start foreign travel for all EU citizens. The certificate would be valid till WHO confirms the end of the COVID-19 pandemic. The objecti...

Read More...
AstraZeneca’s COVID-19 vaccine: A look at recent challenges

AstraZeneca’s COVID-19 vaccine: A look at recent challenges

e links of blood clots after the administration of AstraZeneca’s jab. The COVID-19 vaccine manufactured by Oxford University and AstraZeneca Plc (LON:AZN) has been a part of controversy amid several nations suspending the vaccine's use, in...

Read More...
Pfizer-BioNTech’s COVID-19 vaccine shows 100% efficacy in young adolescents

Pfizer-BioNTech’s COVID-19 vaccine shows 100% efficacy in young adolescents

Source: solarseven, Shutterstock Summary Pfizer-BioNTech’s COVID-19 vaccine has proved to be 100% effective in young adolescents (12-15 years) in Phase 3 clinical study. The two partners plan to submit these data to the US FDA and t...

Read More...